Cancer steals too many good years from our dogs and cats. Vetigenics wants to change that story. This pet biotech firm builds new drugs for pets with cancer. So vets and pet owners now have fresh options to try.
It all starts with a smart shortcut. Vetigenics built its own drug bank, and that bank holds over 40 billion natural dog antibodies. Staff search it to find a match for each cancer type. Best of all, the team skips animal shots in this step. As a result, the work stays fast and kind.
That shortcut has already paid off. One Vetigenics drug treats mouth cancer in dogs. Trials for it ran at North Carolina State and the University of Missouri. A second drug treats bladder cancer in dogs. It was tested at Ethos Vet Health and Bridge Animal Referral Center. Then a third trial paired both drugs together. That trial, called CHECKMATE K9, is now full at five sites.
Vetigenics also backs cancer work that helps dogs and people too. The National Cancer Institute says dogs with cancer can guide human work too. So a cure found for a dog may lead to a cure for us.
None of this happens alone, though. Vetigenics works close with schools, vet clinics, and drug firms. Together, they push new pet drugs from plan to real trial.
Ready to learn more? Visit Vetigenics online, check current trials, and see real science help pets fight cancer today.
